Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
805,782 shares at $34.15 weighted avg; current $33.12 (−3.0%). Executed under Rule 10b5-1 plan adopted Aug 7, 2026. Ongoing accumulation — Nippon Life now holds 125.6M shares total.
Two tranches: 1,332,742 shares at $5.0639 (9/25) + 1,000,000 shares at $4.6062 (9/29); blended avg $4.87. Current $4.96 (+1.8%). Total Pale Fire holding now 28.8M shares.
592,593 shares at $17.00 (IPO price); current $19.94 (+17.3%). ADARx recently IPO'd; SR ONE is a life sciences venture/growth investor taking a large block at offering.
104,511 shares at $44.09 on 9/24; CEO continued buying additional ~47K shares through 9/29 across multiple tranches ($44.50–$45.49 range). Current $47.71 (+8.2%). Strong cluster signal from founder-CEO.
150,600 ordinary shares at HK$17.55–$18.03 (US$2.2583 avg) in Hong Kong open market on 9/29. ADS-equivalent now $9.29 (+2.9%). Post holds 394,474 ordinary shares.
63,000 shares at ~$4.24 avg on 9/29; current $4.30 (+1.4%). Small closed-end fund director open-market buy.
AIThe day in insider buying
SEC Form 4 Insider Scan — October 1, 2026
Scanned the last 24 hours of EDGAR Form 4 filings (covering trades filed Sept 29 – Oct 1, 2026). 6 qualifying buys (≥ $250K, transaction type P) totalling $54.2M.
Headline Filings
CRBG — Nippon Life Insurance Co. (10% Owner) bought 805,782 shares ≈ $27.5M at $34.15 avg; now $33.12 (−3.0% since buy). Executed under a Rule 10b5-1 plan adopted Aug 7, 2026 — pre-programmed accumulation. (filing)
COUR — Pale Fire Capital SE (10% Owner & Director) bought 2,332,742 shares ≈ $11.4M at $4.87 blended avg (9/25 at $5.06; 9/29 at $4.61); now $4.96 (+1.8% since buy). Ongoing accumulation of Coursera near multi-year lows amid AI-disruption concerns in edtech. (filing)
ADRX — SR ONE Capital Management LLC (10% Owner) bought 592,593 shares ≈ $10.1M at $17.00 avg; now $19.94 (+17.3% since buy). ADARx is a recently-IPO'd RNA-targeted pharma; institutional investor buying at offering price signals high conviction. (filing)
NYAX — Yair Nechmad (CEO, Co-Founder & Chairman) bought 104,511 shares ≈ $4.6M at $44.09 avg (Sept 24); now $47.71 (+8.2% since buy). CEO continued buying through Sept 29 with additional tranches totalling ~47K more shares, making this a persistent cluster signal. (filing)
MNSO — Zhang Jingjing Eason (VP & CFO) bought 150,600 ordinary shares ≈ $340K at HK$17.55–$18.03 (US$2.26 avg); ADS now $9.29 (+2.9% since buy on ADS basis). Open-market purchase in Hong Kong by a C-suite insider. (filing)
TSI — Patrick C. Haden (Director) bought 63,000 shares ≈ $267K at ~$4.24 avg; now $4.30 (+1.4% since buy). Small closed-end fund director buying in open market. (filing)
Notes
Sectors & Themes: Financials/Insurance (CRBG), EdTech (COUR), Biotech/RNA pharma (ADRX), Payments/Fintech (NYAX), Retail/Consumer (MNSO), and a Closed-End Fund (TSI). The dominant signal is institutional 10% owners buying large blocks — Nippon Life, Pale Fire Capital, and SR ONE account for $49M of the $54.2M total. The most actionable discretionary signal is the NYAX CEO cluster: Yair Nechmad invested over $4.6M in a single day and kept buying for the rest of the week — a high-conviction, personal-capital bet. ADRX is worth monitoring given SR ONE paid IPO price and the stock is already +17% since that purchase. CRBG is mechanically programmed via 10b5-1, so carries less market-timing information.
Most-bought stocks, last 30 days
RSG$279M · 2 buys, 2 insidersRepublic Services, Inc.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's
stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what
average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free,
and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.